These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8818906)

  • 1. Proposed MIC quality control guidelines for National Committee for Clinical Laboratory Standards susceptibility tests using seven veterinary antimicrobial agents: ceftiofur, enrofloxacin, florfenicol, penicillin G-novobiocin, pirlimycin, premafloxacin, and spectinomycin.
    Marshall SA; Jones RN; Wanger A; Washington JA; Doern GV; Leber AL; Haugen TH
    J Clin Microbiol; 1996 Aug; 34(8):2027-9. PubMed ID: 8818906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality control guidelines for disk diffusion and broth microdilution antimicrobial susceptibility tests with seven drugs for veterinary applications.
    Odland BA; Erwin ME; Jones RN
    J Clin Microbiol; 2000 Jan; 38(1):453-5. PubMed ID: 10618141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardization of broth microdilution and disk diffusion susceptibility tests for Actinobacillus pleuropneumoniae and Haemophilus somnus: quality control standards for ceftiofur, enrofloxacin, florfenicol, gentamicin, penicillin, tetracycline, tilmicosin, and trimethoprim-sulfamethoxazole.
    McDermott PF; Barry AL; Jones RN; Stein GE; Thornsberry C; Wu CC; Walker RD
    J Clin Microbiol; 2001 Dec; 39(12):4283-7. PubMed ID: 11724833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardization of a broth microdilution susceptibility testing method to determine minimum inhibitory concentrations of aquatic bacteria.
    Miller RA; Walker RD; Carson J; Coles M; Coyne R; Dalsgaard I; Gieseker C; Hsu HM; Mathers JJ; Papapetropoulou M; Petty B; Teitzel C; Reimschuessel R
    Dis Aquat Organ; 2005 May; 64(3):211-22. PubMed ID: 15997819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proposed quality control guidelines for National Committee for Clinical Laboratory Standards Susceptibility Tests using the veterinary antimicrobial agent tiamulin.
    Pfaller MA; Jones RN; Walter DH;
    Diagn Microbiol Infect Dis; 2001; 40(1-2):67-70. PubMed ID: 11448566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibility testing of aquatic bacteria: quality control disk diffusion ranges for Escherichia coli ATCC 25922 and Aeromonas salmonicida subsp. salmonicida ATCC 33658 at 22 and 28 degrees C.
    Miller RA; Walker RD; Baya A; Clemens K; Coles M; Hawke JP; Henricson BE; Hsu HM; Mathers JJ; Oaks JL; Papapetropoulou M; Reimschuessel R
    J Clin Microbiol; 2003 Sep; 41(9):4318-23. PubMed ID: 12958263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility testing of Rhodococcus equi: An interlaboratory test.
    Riesenberg A; Kaspar H; Feßler AT; Werckenthin C; Schwarz S
    Vet Microbiol; 2016 Oct; 194():30-35. PubMed ID: 26711505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimum inhibitory concentration determinations for various antimicrobial agents against 1570 bacterial isolates from turkey poults.
    Salmon SA; Watts JL
    Avian Dis; 2000; 44(1):85-98. PubMed ID: 10737648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-evaluations of disk diffusion quality control ranges for 11 drugs: report from the QC working group of the national committee for clinical laboratory standards.
    Jones RN; Cullen S
    Int J Antimicrob Agents; 2002 Oct; 20(4):289-92. PubMed ID: 12385686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of BMS284756 MIC and 5-microg disk diffusion quality control studies tested against seven American type culture collection strains.
    Biedenbach DJ; Jones RN;
    Diagn Microbiol Infect Dis; 2001 Dec; 41(4):225-8. PubMed ID: 11777665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishing quality control ranges for antimicrobial susceptibility testing of Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus: a cornerstone to develop reference strains for Korean clinical microbiology laboratories.
    Hong SK; Choi SJ; Shin S; Lee W; Pinto N; Shin N; Lee K; Hong SG; Kim YA; Lee H; Kim H; Song W; Lee SH; Yong D; Lee K; Chong Y
    Ann Lab Med; 2015 Nov; 35(6):635-8. PubMed ID: 26354353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility testing and quality control parameters for sarafloxacin (A-56620): a fluoroquinolone used for treatment and control of colibacillosis in poultry. Quality Control Study Group.
    Jones RN; Erwin ME
    Diagn Microbiol Infect Dis; 1998 Sep; 32(1):55-64. PubMed ID: 9791759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility testing quality control studies with fosfomycin tromethamine.
    Fuchs PC; Barry AL; Brown SD
    Eur J Clin Microbiol Infect Dis; 1997 Jul; 16(7):538-40. PubMed ID: 9272392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Broth Microdilution MIC and Disk Diffusion Antimicrobial Susceptibility Test Quality Control Ranges for the Combination of Cefepime and the Novel β-Lactamase Inhibitor Enmetazobactam.
    Belley A; Huband MD; Fedler KA; Watters AA; Flamm RK; Shapiro S; Knechtle P
    J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31167844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimum inhibitory concentration quality-control guidelines for biapenem, DU-6859a, FK-037, levofloxacin, grepafloxacin, and ceftizoxime when using various National Committee for Clinical Laboratory Standards susceptibility test methods. Quality Control Study Group.
    Bale MJ; Jones RN; Erwin ME
    Diagn Microbiol Infect Dis; 1994 May; 19(1):65-8. PubMed ID: 7956017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality control guidelines for cefdinir, cefepime, cefetamet, cefmetazole, cefpodoxime, cefprozil, and clinafloxacin (CI-960) for various National Committee for Clinical Laboratory Standards susceptibility testing methods. Quality Control Study Group.
    Bale MJ; Jones RN
    J Clin Microbiol; 1993 Sep; 31(9):2538-40. PubMed ID: 8408586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of MIC Quality Control Ranges for the Novel Gyrase Inhibitor Zoliflodacin.
    Miller AA; Traczewski MM; Huband MD; Bradford PA; Mueller JP
    J Clin Microbiol; 2019 Sep; 57(9):. PubMed ID: 31315953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proposed quality control guidelines for antimicrobial susceptibility tests using tilmicosin.
    Shryock TR; White DW; Werner CS; Staples JM
    J Clin Microbiol; 1995 Feb; 33(2):331-5. PubMed ID: 7714188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MIC quality control guidelines for Haemophilus susceptibility tests using cefdinir (FK482), cefepime, cefetamet, cefpirome, ceftibuten, fleroxacin, temafloxacin, clarithromycin, RP59500, and trospectomycin.
    Bale MJ; Jones RN; Erwin ME; Koontz FP; Gerlach EH; Murray PR; Washington JA
    J Clin Microbiol; 1992 Jan; 30(1):225-6. PubMed ID: 1310329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Method preferences and test accuracy of antimicrobial susceptibility testing: updates from the College of Amercian Pathologists Microbiology Surveys Program.
    Jones RN;
    Arch Pathol Lab Med; 2001 Oct; 125(10):1285-9. PubMed ID: 11570902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.